Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mamodikoe K Makhene"'
Autor:
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, Anne F Luetkemeyer, David J Diemert, Patricia L Winokur, Rachel M Presti, Angelica C Kottkamp, Ann R Falsey, Sharon E Frey, Richard Rupp, Martín Bäcker, Richard M Novak, Emmanuel B Walter, Lisa A Jackson, Susan J Little, Lilly C Immergluck, Siham M Mahgoub, Jennifer A Whitaker, Tara M Babu, Paul A Goepfert, Dahlene N Fusco, Robert L Atmar, Christine M Posavad, Antonia Netzl, Derek J Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K Makhene, Sonja Crandon, David C Montefiori, Paul C Roberts, John H Beigel
Publikováno v:
Clinical Infectious Diseases.
In a randomized clinical trial, we compare early neutralizing antibody responses after boosting with bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines based on either BA.1 or BA.4/BA.5 Omicron spike p
Autor:
Justin R Ortiz, David I Bernstein, Daniel F Hoft, Christopher W Woods, Micah T McClain, Sharon E Frey, Rebecca C Brady, Christopher Bryant, Ashley Wegel, Robert W Frenck, Emmanuel B Walter, Getahun Abate, Sarah R Williams, Robert L Atmar, Wendy A Keitel, Nadine Rouphael, Mathew J Memoli, Mamodikoe K Makhene, Paul C Roberts, Kathleen M Neuzil
Publikováno v:
The Journal of Infectious Diseases.
Background We evaluated the associations between baseline influenza virus–specific hemagglutination inhibition (HAI) and microneutralization (MN) titers and subsequent symptomatic influenza virus infection in a controlled human infection study. Met
Autor:
Franklin R Toapanta, Paula Bernal, Jingping Hu, Paul C Roberts, Catherine J Luke, Mamodikoe K Makhene, Justin Ortiz, Kathleen Neuzil, Marcelo Sztein
Publikováno v:
Open Forum Infectious Diseases. 9
Background Influenza vaccines require yearly updates due to constant antigenic drift. Improvement of current vaccines requires a deep understanding of the pathogen as well as immunity to the virus. Controlled Human Infection Models (CHIM) provide opp
Autor:
Justin R. Ortiz, David I. Bernstein, Daniel F. Hoft, Christopher W. Woods, Micah T. McClain, Sharon E. Frey, Rebecca C. Brady, Christopher Bryant, Ashley Wegel, Robert W Frenck, Emmanuel B. Walter, Getahun Abate, Sarah R. Williams, Robert L. Atmar, Wendy A. Keitel, Nadine Rouphael, Mathew J. Memoli, Mamodikoe K. Makhene, Paul C. Roberts, Kathleen M. Neuzil
BackgroundInfluenza controlled human infection model (CHIM) studies can advance development of vaccines and therapeutics. Our objective was to evaluate the associations between baseline challenge virus-specific hemagglutination inhibition (HAI) and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c54a95ec1c50e74c8573d24bb4bfcb5
https://doi.org/10.1101/2022.09.27.22280383
https://doi.org/10.1101/2022.09.27.22280383
Autor:
Mamodikoe K. Makhene, Pamela S. Diaz
Publikováno v:
The Pediatric Infectious Disease Journal. 12:836-839
We evaluated clinical presentations and complications retrospectively in 48 pediatric patients hospitalized for suspected measles during a measles epidemic in Chicago. Fifty-one percent were < 15 months of age and 75% were < 4 years of age. Measles,
Autor:
Mamodikoe K. Makhene, Mary Lou Clements-Mann, Roberta Casey, Peter F. Wright, Ruth A. Karron, Juliette Thompson, James E. Crowe, Brian R. Murphy
Publikováno v:
The Journal of infectious diseases. 176(6)
Two live-attenuated, cold-passaged (cp), temperature-sensitive (ts) candidate vaccines, designated cpts530/1009 and cpts248/955, were attenuated, genetically stable, and immunogenic in chimpanzees and were highly attenuated for human adults. In respi